CINDY MESMER: Open Payments
NPI 1326478728 · HYANNIS, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,438 in 59 payments from 20 companies in 2025. Trend: 2023 $520 · 2024 $1,048 · 2025 $1,438
Food & beverage: $1,438
| Company | Payments | Amount |
|---|---|---|
| Endo USA, Inc. | 6 | $182 |
| Sumitomo Pharma America, Inc. | 8 | $165 |
| Ferring Pharmaceuticals Inc. | 4 | $156 |
| TOLMAR, INC. | 8 | $148 |
| Janssen Biotech, Inc. | 6 | $136 |
| ACCORD HEALTHCARE, INC. | 5 | $121 |
| IMMUNITYBIO, INC. | 4 | $89 |
| Dendreon Pharmaceuticals LLC | 4 | $88 |
| UROGEN PHARMA, INC. | 1 | $49 |
| ABBVIE INC. | 2 | $47 |
Products named: ADSTILADRIN, XIAFLEX, ERLEADA, GEMTESA, Camcevi, JATENZO, ANKTIVA, PROVENGE.
Industry payments across MA — which companies pay providers there.
